Our Team

As a non-profit organization, ACRES is led by its Executive Office and Board of Directors. These individuals are internationally-recognized and respected individuals who are champions for innovation and integration in clinical research.

In addition, several experts from academia, industry, regulatory agencies, research sites, patient advocates and the ethics community make up the ACRES Global Steering Committee which provides advise and guidance to ACRES Leadership.

The ACRES Alliance is a consortium of like-minded organizations and stakeholders that share the ACRES vision and bring their expertise to the ACRES initiatives.

Board of Directors

Greg Koski, PhD, MD

Chairman

Co-Founder & President / Chief Executive Officer, ACRES
Senior Scientist, James Mongan Institute for Health Policy
Associate Professor of Anesthesia, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Briggs Morrison

Board Member

CEO, Syndax Pharmaceuticals
Managing Director, MPM Capital

Eve E. Slater

Board Member

Associate Professor of Clinical Medicine, Columbia University; former Senior Vice President, Worldwide Policy at Pfizer; former Senior Vice President for External Policy at Merck; former Assistant Secretary for Health, US Department of Health and Human Services

Rebecca Kush

Board Member

Founder and President, Clinical Data Interchange Standards Consortium (CDISC)

Brendan Buckley, PhD

Board Member

Former Chief Medical Officer of ICON; Chairperson, Fighting Blindness; Director, European Collaborative Centre for Clinical Trials in Rare Diseases and Irish Medicines Board; EMA Scientific Advisory Committee on Diabetes and Metabolism

Bob Stewart

Board Member

CEO, EXOCHAIN, CORP; Chief Technology Officer, ACRES;
Recently, COO and Board Member, Sonavation; Formerly, CTO, EMC Global Security Group; CTO, Verified Person; Co-founder & CTO, CyberMedica; CTO, CMGI Incubator; CTO, Motorola, Internet and Networking Group

Badhri Srinivasan, ABD, BioStatistics

Board Member

Head, Global Development Operations, Novartis; Previously, CEO and co-founder of Remarque Systems (technology); SVP and Global Head, Data and Safety Monitoring, Quintiles; VP of Enterprise Analytics and Business Process Management, Quintiles Innovation

Vidula Sukhatme MS

Board Member

Founder & CEO at GlobalCures, Inc.
Previously, Information Systems Consultant , Childrens Hospital and Beth Israel (Boston), Lahey Clinic, Bradlees, Northwestern Memorial (Chicago)

Henry D. Levy

Board Member

Veeva Systems, Chief Strategy Officer; Previously, Chief Commercial Officer, PPD, Inc;
Accenture LLP, Global Managing Director, Accenture Life Sciences R&D

Ranga Krishnan

Board Member

Dean, Duke-National University of Singapore Graduate School of Medicine Professor and Chair, Department of Psychiatry, Duke University School of Medicine

Executive Office

Greg Koski, PhD, MD

Co-Founder & President / Chief Executive Officer

Senior Scientist, James Mongan Institute for Health Policy Associate Professor of Anesthesia,  Massachusetts General Hospital Harvard Medical School, Boston, MA

Matthew D. Whalen, PhD

Chief Operating Officer

Principal, IMPACT LLC, Gambrills, MD; Co-Founder, Chesapeake IRB

Mary F. Tobin, PhD

Special Advisor to the President / Chief Executive Officer

Founder and Managing Director, IMPACT LLC, Gambrills, MD; Formerly: Outside Lead Consultant, OPM; University of Maryland, College Park University Honors Program

Diana Howard

Director Administration and Finance

Bob Stewart

Chief Technology Officer

CEO, EXOCHAIN, CORP; Chief Technology Officer, ACRES;
Recently, COO and Board Member, Sonavation; Formerly, CTO, EMC Global Security Group; CTO, Verified Person; Co-founder & CTO, CyberMedica; CTO, CMGI Incubator; CTO, Motorola, Internet and Networking Group

Larry Kennedy, PhD

VP, Quality Management Systems, Chief Quality Officer (CQO)

Chair of the Site Accreditation and Standards Initiative (SASI); CEO Quality Management Institute

Brian Edwards, MD

VP, Safety & Pharmacovigilance

Principal Consultant, NDA Regulatory Science Ltd, Surrey, UK Director of International; Society of Pharmacovigilance Secretariat Ltd, UK

Al O. Pacino II

VP, Collaborative Network Development

President, HealthCarePoint
ACRP; Past Chair Central Texas Chapter
Global Advisory Board Member
VP Collaborative Network Development; SCRS Global Impact Partner Board Member

Beat Widler

VP, Auditing & Monitoring Systems

Widler & Schiemann Ltd, Quality Risk Management & Quality by Design Former Global Head Quality, Hoffmann-La Roche Ltd., Basel, Switzerland

Sandor Kerpel-Fronius, MD

VP, Global Development

Sr Scientific Advisor /Professor, Clinical Pharmacology, Semmelweis University, Budapest, Hungary
General Director, Hungarian National Institute of Pharmacy;
Serves on Executive Board of the IMI-PharmaTrain.

Dennis J. LaCroix, Esq.

General Counsel

Formerly: Internal Counsel, Genzyme

Ex-Officio Board of Directors

Beat Widler

Ex-Officio Director

Widler & Schiemann Ltd, Quality Risk Management & Quality by Design Former Global Head Quality, Hoffmann-La Roche Ltd., Basel, Switzerland

Andrew Olmstead

Ex-Officio Director

Executive Vice President, Research Dataware, LLC, (a WIRB-Copernicus Group Company), Cambridge, MA